NM_004643.4:c.30_32dupAGC

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 1P and 2B. PP5BS1_SupportingBS2_Supporting

The NM_004643.4(PABPN1):​c.30_32dupAGC​(p.Ala11dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000478 in 1,198,220 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00050 ( 0 hom. )

Consequence

PABPN1
NM_004643.4 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1

Conservation

PhyloP100: 1.57

Publications

0 publications found
Variant links:
Genes affected
PABPN1 (HGNC:8565): (poly(A) binding protein nuclear 1) This gene encodes an abundant nuclear protein that binds with high affinity to nascent poly(A) tails. The protein is required for progressive and efficient polymerization of poly(A) tails at the 3' ends of eukaryotic transcripts and controls the size of the poly(A) tail to about 250 nt. At steady-state, this protein is localized in the nucleus whereas a different poly(A) binding protein is localized in the cytoplasm. This gene contains a GCG trinucleotide repeat at the 5' end of the coding region, and expansion of this repeat from the normal 6 copies to 8-13 copies leads to autosomal dominant oculopharyngeal muscular dystrophy (OPMD) disease. Related pseudogenes have been identified on chromosomes 19 and X. Read-through transcription also exists between this gene and the neighboring upstream BCL2-like 2 (BCL2L2) gene. [provided by RefSeq, Dec 2010]
BCL2L2-PABPN1 (HGNC:42959): (BCL2L2-PABPN1 readthrough) This locus represents naturally occurring read-through transcription between the neighboring BCL2L2 (BCL2-like 2) and PABPN1 (poly(A) binding protein, nuclear 1) genes on chromosome 14. The read-through transcript encodes a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PP5
Variant 14-23321490-G-GGCA is Pathogenic according to our data. Variant chr14-23321490-G-GGCA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1323406.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=1}.
BS1
Variant frequency is greater than expected in population eas. GnomAdExome4 allele frequency = 0.000499 (523/1047284) while in subpopulation EAS AF = 0.00115 (26/22638). AF 95% confidence interval is 0.000805. There are 0 homozygotes in GnomAdExome4. There are 258 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 50 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PABPN1NM_004643.4 linkc.30_32dupAGC p.Ala11dup disruptive_inframe_insertion Exon 1 of 7 ENST00000216727.9 NP_004634.1 Q86U42-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PABPN1ENST00000216727.9 linkc.30_32dupAGC p.Ala11dup disruptive_inframe_insertion Exon 1 of 7 1 NM_004643.4 ENSP00000216727.4 Q86U42-1
BCL2L2-PABPN1ENST00000553781.5 linkc.433-682_433-680dupAGC intron_variant Intron 3 of 8 2 ENSP00000451320.1 Q92843-2

Frequencies

GnomAD3 genomes
AF:
0.000332
AC:
50
AN:
150828
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000727
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000198
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000773
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000592
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000285
AC:
2
AN:
7014
AF XY:
0.000540
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000531
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000499
AC:
523
AN:
1047284
Hom.:
0
Cov.:
31
AF XY:
0.000519
AC XY:
258
AN XY:
497094
show subpopulations
African (AFR)
AF:
0.0000468
AC:
1
AN:
21354
American (AMR)
AF:
0.000711
AC:
5
AN:
7034
Ashkenazi Jewish (ASJ)
AF:
0.000243
AC:
3
AN:
12336
East Asian (EAS)
AF:
0.00115
AC:
26
AN:
22638
South Asian (SAS)
AF:
0.000103
AC:
2
AN:
19364
European-Finnish (FIN)
AF:
0.0000430
AC:
1
AN:
23230
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2728
European-Non Finnish (NFE)
AF:
0.000523
AC:
470
AN:
898012
Other (OTH)
AF:
0.000370
AC:
15
AN:
40588
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000331
AC:
50
AN:
150936
Hom.:
0
Cov.:
32
AF XY:
0.000312
AC XY:
23
AN XY:
73758
show subpopulations
African (AFR)
AF:
0.0000725
AC:
3
AN:
41392
American (AMR)
AF:
0.000198
AC:
3
AN:
15156
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.000775
AC:
4
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10050
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000592
AC:
40
AN:
67598
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000108
Hom.:
0
Asia WGS
AF:
0.000582
AC:
2
AN:
3452

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Oculopharyngeal muscular dystrophy Pathogenic:1
Jan 18, 2024
Revvity Omics, Revvity
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oculopharyngeal muscular dystrophy 1 Uncertain:1
-
Juno Genomics, Hangzhou Juno Genomics, Inc
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PM4+PS4_Supporting -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.6
Mutation Taster
=77/23
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1401656265; hg19: chr14-23790699; API